Options360

BIIB earnings

Long
NASDAQ:BIIB   Biogen Inc.
Biogen (BIIB) earnings are on Wednesday, July 19th, 2023, at 7:15am. Biogen (BIIB) reported Q1 March 2023 earnings of 3.40 per share on revenue of 2.5 billion. The consensus earnings estimate was 3.25 per share on revenue of 2.4 billion. The company said it continues to expect 2023 earnings of 15.00 to 16.00 per share. The current consensus earnings estimate is 15.47 per share for the year ending December 31, 2023.

Q2 June 2023 Consensus:
EPS = 3.70
Revenue = 2.38 B
PE = 12.7

100SMA = 290
200SMA = 279

BIIB 1 day (24hr ext.) chart TTCATR 20VWMA levels:

R3 = 317
R2 = 309
R1 = 302
pivot = 294
S1 = 286
S2 = 279
S3 = 271

Options data:

7/14 expiry
Put Volume Total 723
Call Volume Total 2,716
Put/Call Volume Ratio 0.27
Put Open Interest Total 257
Call Open Interest Total 1,277
Put/Call Open Interest Ratio 0.20

7/21 expiry
Put Volume Total 602
Call Volume Total 2,380
Put/Call Volume Ratio 0.25
Put Open Interest Total 5,614
Call Open Interest Total 10,199
Put/Call Open Interest Ratio 0.55

8/18 expiry
Put Volume Total 206
Call Volume Total 726
Put/Call Volume Ratio 0.28
Put Open Interest Total 436
Call Open Interest Total 795
Put/Call Open Interest Ratio 0.55


Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.